You are here:
As a public-private partnership including civil society, the Vaccine Alliance plays a catalytic role providing funding to countries and demonstrates "added-value" by:
Gavi Strategy 2011-2015: Business plan
Gavi Strategy & Business Plan
Investing in Gavi’s 2016-2020 strategy has the potential to deliver US$ 80-100 billion in costs averted related to illness, such as productivity loss due to death/disability, treatment costs, caretaker productivity loss and transport costs.
© Gavi 2014
modal window here